Dorsey Wright & Associates’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
SCC
GKFF
OCMI
TAM
KI
DCM
ECA
Dorsey Wright & Associates's ASPN Position: Q1 2022 in Review
Dorsey Wright & Associates sold out of Aspen Aerogels (ASPN) in Q1 2022, closing a stake of 2,655 shares — an estimated $132K sold.
Dorsey Wright & Associates first reported a position in ASPN in Q1 2020 and held it in 7 quarters. The position peaked at $132K in Q4 2021. 145 funds tracked by Wall St. Rank hold ASPN as of Q1 2022.
- Dorsey Wright & Associates reported no remaining Aspen Aerogels position as of Q1 2022 after selling out during the quarter.
- Dorsey Wright & Associates sold 2,655 Aspen Aerogels shares in Q1 2022, an estimated $132K.
- Dorsey Wright & Associates first reported a position in Aspen Aerogels in Q1 2020 and held it in 7 quarters.
- Dorsey Wright & Associates's Aspen Aerogels position peaked at $132K in Q4 2021.
- 145 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2022.
Based on Dorsey Wright & Associates's 13F filing for Q1 2022, filed 27 Apr 2022.